What is the level of liabilities of Cerus this year?
Cerus has a debt balance of 145.1 M USD this year.
Cerus Liabilities 2024
Cerus Liabilities
145.1 M USD
Cerus Dividend yield
Ticker
CERS
ISIN
US1570851014
WKN
905249
In 2024, Cerus's total liabilities amounted to 145.1 M USD, a -3.59% difference from the 150.5 M USD total liabilities in the previous year.
Cerus Aktienanalyse
What does Cerus do?
Cerus Corporation is a biotechnology company specialized in the development and marketing of products for the processing and transfusion of blood products. The company was founded in 1991 and is headquartered in Concord, California. Cerus Corporation is listed on the NASDAQ stock exchange and employs approximately 450 employees worldwide. The history of Cerus Corporation began when its founder, Stephen Isaacs, received a blood transfusion and subsequently became infected with the Hepatitis B virus. This incident inspired him to start a company focusing on the development of technologies for the safe transfusion of blood products. In 1993, Cerus Corporation introduced its first product, the Intercept Blood System. This system utilized ultraviolet light and chemicals to deactivate pathogens such as viruses, bacteria, and parasites in blood. The business model of Cerus Corporation revolves around the development and distribution of products for medical needs. The company's focus is on the processing of blood products such as platelets, plasma, and red blood cells to reduce the risk of infectious diseases and other potentially harmful side effects in blood transfusions. Cerus also provides training and technical support for its products. Cerus Corporation has several divisions, including the Intercept Blood System, Blood Center Technology, and Innovative Technology. The Intercept Blood System division is the largest and most popular, offering products such as the Intercept Blood System for platelets and plasma, the Intercept Blood System for red blood cells, the Intercept Blood System for PAS (reduced volume blood bank) and the Intercept Blood System for Fresh Frozen Plasma. Cerus Corporation's Blood Center Technology division provides technologies and devices for blood banks and transfusion services, including transfusion safety systems and blood testing devices. The Innovative Technology division specializes in the development of new technologies and products. Another product of Cerus Corporation is INTERCEPT FDA Approved Plasma, which was approved by the US Food and Drug Administration (FDA) in 2018. The plasma is made from donated blood and processed using the INTERCEPT technology. The INTERCEPT technology decontaminates various blood components, increasing their safety in transfusions. Cerus Corporation has achieved significant success in the medical technology industry. Cerus Corporation's Intercept Blood System is approved in more than 25 countries and has helped save countless lives and prevent diseases for healthcare professionals and patients. The company has been recognized multiple times for its innovative products and services, including receiving the Gold Medal at the Edison Awards in 2017 and the Technology Pioneer Award from the World Economic Forum in 2016. In summary, Cerus Corporation is a successful biotechnology company that develops and distributes innovative technologies for the processing and transfusion of blood products. Through its technology and products, Cerus contributes to increasing the safety of blood transfusions by reducing the risk of infectious diseases and other potentially dangerous side effects. Cerus Corporation will continue to play an important role in the medical technology industry in the future. Cerus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Cerus's Liabilities
Cerus's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cerus's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Cerus's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Cerus's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Cerus’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Cerus Stock
What were the liabilities of Cerus compared to the previous year?
The liabilities of Cerus have increased by -3.59% dropped compared to the previous year.
What are the consequences of high debt for investors of Cerus?
High liabilities can pose a risk for investors of Cerus, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Cerus?
Low liabilities mean that Cerus has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Cerus affect the company?
An increase in liabilities of Cerus can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Cerus affect the company?
A decrease in the liabilities of Cerus can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Cerus?
Some factors that can influence the liabilities of Cerus include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Cerus so important for investors?
The liabilities of Cerus are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Cerus take to modify the liabilities?
To change its liabilities, Cerus can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Cerus pay?
Over the past 12 months, Cerus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerus is expected to pay a dividend of 0 USD.
What is the dividend yield of Cerus?
The current dividend yield of Cerus is .
When does Cerus pay dividends?
Cerus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cerus?
Cerus paid dividends every year for the past 0 years.
What is the dividend of Cerus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cerus located?
Cerus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cerus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cerus from 6/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2024.
When did Cerus pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Cerus in the year 2023?
In the year 2023, Cerus distributed 0 USD as dividends.
In which currency does Cerus pay out the dividend?
The dividends of Cerus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cerus
Our stock analysis for Cerus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
